cas9
Broad Institute maintains patents to Gene Scissors in the US
By Joanna Applequist | Posted on February 17, 2017
The CRISPR-Cas9 technology, the so called “gene scissors” which allow for targeted genome-editing, is subject to a patent dispute between two research teams lead by Jennifer Doudna at UC Berkeley and Emanuelle Charpentier then at the University of Vienna on one hand, and Feng Zhang’s lab at the Broad Institute and MIT on the other....
Tags: cas9, crispr, crispr-cas9
Recent contributors
Partner, Attorney at Law, Business Area Manager
Partner, European Patent Attorney
Senior Counsel, European Patent Attorney
Counsel, AU and NZ Patent Attorney
Senior Associate, China Patent Attorney
Senior Associate, Attorney at Law